Open AccessConcise Review: Drug Discovery in the Age of the Induced Pluripotent Stem Cell
Author(s) -
Ko Huaising C.,
Gelb Bruce D.
Publication year - 2014
Publication title -
stem cells translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.781
H-Index - 71
eISSN - 2157-6580
pISSN - 2157-6564
DOI - 10.5966/sctm.2013-0162
Subject(s) - induced pluripotent stem cell , drug discovery , clinical trial , drug , drug development , medicine , disease , pharmacology , bioinformatics , computational biology , human induced pluripotent stem cells , neuroscience , biology , embryonic stem cell , pathology , genetics , gene
The growing number of human disease models made with patient‐specific induced pluripotent stem cells (iPSCs) has made it possible to conduct research on a wide range of disorders. This review surveys the incorporation of iPSC technology into drug therapy development, which holds promise as a powerful and nuanced approach to personalized medicine.